Company · CIK 0001869105
BridgeBio Oncology Therapeutics, Inc.
BBOTSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$2.14−$0.21 (−8.94%)
BBOT · Last trade
- Prev close
- $2.35
- Range (30d)
- $2.04 – $2.95
On the record
Recent filings
- 8-KBBOTCurrent report0001193125-26-385225 · 5.0 MBSEC(opens sec.gov)
- 10-QBBOTQuarterly update0001193125-26-344661 · 10.8 MBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-344608 · 416.8 KBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-277513 · 148.3 KBSEC(opens sec.gov)
- 10-QBBOTQuarterly update0001193125-26-219829 · 12.7 MBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-219801 · 390.2 KBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-191512 · 144.1 KBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-170888 · 184.3 KBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-126493 · 143.4 KBSEC(opens sec.gov)
- 8-KBBOTCurrent report0001193125-26-093997 · 784.9 KBSEC(opens sec.gov)
Insiders
- Bauer JakeDirector
- Beltran PedroDirector, President and CEO
- Ben YongChief Med & Dev Officer
- BridgeBio Pharma, Inc.10% Owner
- BridgeBio Pharma LLC10% Owner
- Chen BihuaDirector, 10% Owner
- Cobo MarcPrincipal Accounting Officer
- DOIG MICHELLEDirector
- Elmelech IdanCOO & Principal Financial Ofcr
- Helix Holdings II LLCDirector, 10% Owner
Tickers
Addresses
business
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA, 94080
mailing
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA, 94080
Former names
- Helix Acquisition Corp. II2025-08-06
Same industry